At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
Continuous glucose monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
IMPlementation of Continuous Glucose Monitoring in Children With Type 2 Diabetes
In Brief
A clinical study evaluating Continuous glucose monitor for Type 2 Diabetes and Hyperglycemia Due to Type 2 Diabetes Mellitus. Completed, enrolled 41 participants across 1 site.
Detailed Summary
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJan 2021
First PostedJan 2021
Primary CompletionJul 2022
TodayJul 2026
First PostedJan 22, 2021
Enrollment StartJan 17, 2021
Primary CompletionJul 28, 2022
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 5.4 years ago
Interventions
Continuous glucose monitordevice
Eligible patients will have a Dexcom G6 Continuous Glucose Monitor placed for 10 days.